提取,净化和应用素减轻肥胖:一个全面的审查
Chunmei Liu1, Li Wei1, Hengyuan Zhang1
1College of Food Science, Southwest University, Chongqing 400715, China.
Food chemistry
|January 8, 2026
概括
素表现出抗肥胖作用,但其有效性取决于摄入方法和宿主因素. 需要进一步的研究来解决功能性食品开发的安全问题.
科学领域:
- 药理学和营养科学 药理学和营养科学
- 自然产品化学 自然产品化学
背景情况:
- 素因其抗肥胖特性而闻名,在各种实验模型和人类研究中得到证实.
- 素的有效性是由外部因素 (例如,类型,剂量,摄入量) 和宿主特定因素 (生理学,肠道微生物群) 调节的.
- 有限的安全评估阻碍了基于素的功能性食品的开发.
研究的目的:
- 审查素提取和净化方法.
- 阐明素抗肥胖作用背后的机制.
- 讨论影响素生理功能的因素,并建议利用它的策略.
主要方法:
- 文献综述侧重于素提取,净化,抗肥胖机制和影响因素.
- 来自细胞,动物和人类研究的数据的综合.
- 对功能性食品应用相关的安全数据的分析.
主要成果:
- 素通过各种途径表现出抗肥胖效应,受到管理和宿主因素的影响.
- 提取和净化技术对于获得有效的素至关重要.
- 肠道微生物群和宿主生理学在调解素的作用方面发挥着重要作用.
- 安全数据仍然是需要进一步调查的关键领域.
结论:
- 素具有作为抗肥胖剂的潜力,但其应用需要仔细考虑影响因素和安全性.
- 需要优化提取,净化和管理策略.
- 解决安全问题对于功能性食品中素的成功开发至关重要.
- 这一审查为素的增值利用提供了基础.
相关概念视频
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
235
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
235
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
165
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
165